Jorge SolizEdith M. Schneider GasserChristian Arias‐ReyesFernanda Aliaga‐RaduánLiliana Poma-MachicaoGustavo Zubieta‐CallejaWerner I. FuruyaPedro Trevizan‐BaúRishi R. DhingraMathias Dutschmann2026-03-222026-03-22202010.1016/j.resp.2020.103476https://doi.org/10.1016/j.resp.2020.103476https://andeanlibrary.org/handle/123456789/85568Citaciones: 88enMedicineErythropoietinHypoxemiaIntensive care medicineHypoxia (environmental)Respiratory systemContext (archaeology)RhinovirusImmunologyInternal medicineCoping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?review